Role of Lactobacillus in the Prevention of Antibiotic‐Associated Diarrhea: A Meta‐analysis

Abstract

Administration of a Lactobacillus single-agent regimen as a prophylactic agent during antibiotic treatment reduced the risk of developing AAD compared with placebo in adults but not pediatric patients.

Potential probiotics from faecal specimens of breastfed Nigerian infants as a therapy for bacterial gastroenteritis

“…reuteri CH1 had the lowest resistance (23.3%) towards the test antibiotics, survived 3% physiological bile, simulated pH (3.0-9.5), and exhibited significant spectrum of inhibitory activities against 7 reference strains and 12 selected gastroenteritic strains from children (Table 3). [2] 100.0 100.0 100.0 Cotrimoxazole [4] 30.6 43.8 70.0 Erythromycin [2] 81.8 100.0 100.0 Metronidazole [8] 77.1 84.4 86.1 NANT [5] 100.0 100.0 100.0 NANT = non antibiotic anti-gastroenteritic medications …”

Role of Probiotics in Prevention and Treatment of Antibiotic-Associated Diarrhea in Children

“…Сохранение и коррекция микроэкологии кишечника тре-бует назначение пробиотиков, цитомукопротекторов, метаболитов бактерий-симбионтов и продуктов функ-ционального питания на основе молочнокислых бактерий и др. [31][32][33][34][35].…”

Possibilities of Correction and Prophylaxis of Intestinal Microbiocenosis Disorders in Frequently Ill Children

“…В частности, было доказано, что применение пробио-тиков снижает риск развития ААД у детей на 28,5% [17][18][19]. В настоящее время широкое распространение в практической педиатрии получили препараты, содер-жащие в своем составе такие микроорганизмы, как L. acidophilus, Lactobacillus bulgaricus, B. longum, E. faecium, Saccharomyces boulardii [14,20].…”